SecBot SecBot
8-K ·Filed Aug 11, 2026

TNGX

Tango Therapeutics, Inc.
BEARISH
Impact 6/10
Horizonweeks Processed3mo ago SEC0001193125-26-344997
8-K context-dependent: Items 8.01
Actionable Insight ▼ Bearish

The 4x upsizing of the ATM facility without a disclosed catalyst creates significant overhang. Traders should watch for actual ATM sales via daily volume patterns and any subsequent 8-K or prospectus supplement disclosing use of proceeds. The stock may trade under pressure as the market prices in potential dilution.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$25.58
T+0 close · Aug 11, 2026 · via day close
Latest settled
−9.38%
T+60 · $23.18
Vs SPY
−4.51%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 12 $25.58entry
  2. T+1 · 3mo ago +0.27%α −0.42% · $25.65
  3. T+5 · 3mo ago −1.49%α −1.04% · $25.20
  4. T+20 · 2mo ago −8.64%α −6.74% · $23.37
  5. T+60 · 12d ago −9.38%α −4.51% · $23.18
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Tango Therapeutics upsized its at-the-market (ATM) equity offering program from $100M to $400M, terminating the prior $100M facility under which $64.4M had already been sold. The new $400M shelf capacity represents a 4x increase in potential dilution, signaling aggressive capital raising for a biotech with a $4.0B market cap. This is a bearish signal as it dramatically expands the overhang of potential share issuance without any disclosed use of proceeds or operational catalyst to justify the dilution.

Key Facts

  • Tango Therapeutics upsized its ATM offering from $100M to $400M in aggregate offering price.
  • $64.4M of shares had already been sold under the prior $100M program.
  • The prior $100M prospectus supplement has been terminated; the new $400M supplement includes the remaining $35.6M of unsold shares.
  • The new shares are offered under the existing S-3ASR registration statement (File No. 333-291684) filed November 21, 2025.
  • No specific use of proceeds or operational catalyst was disclosed to justify the 4x increase in potential dilution.

Financial Impact

Potential dilution of up to $400M in new common stock, representing ~10% of the $4.0B market cap if fully drawn; $64.4M already sold under prior facility.

dilutionshare countmarket cap

Risk Factors

  • Dilution risk from up to $400M in new shares being sold into the market.
  • No disclosed use of proceeds creates uncertainty about capital allocation.
  • ATM sales could pressure the stock price if executed aggressively.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (19 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-344997
Document: d131656dex51.htm0001193125-26-344997
Document: 0001193125-26-344997-index-headers.html0001193125-26-344997
Document: 0001193125-26-344997-index.html0001193125-26-344997
Document: 0001193125-26-344997.txt0001193125-26-344997

Track record

27 reports on TNGX

Performance horizon

2 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +29.28% at T+60 after the Jun 8, 2026 report. 4 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $24.22 Now $24.17 +0.21% settles Feb 16
  2. Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $24.50 Now $24.17 +1.35% settles Feb 12
  3. Nov 9, 20267d ago Press Release Neutral 5/10 Entry $22.74 Now $24.17 +6.29% settles Feb 5
  4. Nov 6, 202610d ago SC 13G/A Neutral 2/10 Entry $21.50 Now $24.17 +12.42% settles Feb 4
  5. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $20.87 Now $24.17 +15.81% settles Feb 3
  6. Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $23.17 Now $24.17 +4.32% settles Feb 1
  7. Nov 2, 202614d ago 144 Neutral 2/10 Entry $23.17 Now $24.17 +4.32% settles Feb 1
  8. Oct 23, 202624d ago 8-K Bullish 7/10 Entry $23.34 Now $24.17 +3.56% settles Jan 21
  9. Aug 11, 202613w ago 8-K Bearish 6/10 Viewing Entry $25.58 to $23.18 Now $24.17 +5.51% ▲ +9.38% +4.51% vs SPY
  10. Aug 11, 202613w ago 8-K Bullish 7/10 No price data
Showing 10 of 27

US Market Status

Market Closed · Opens in 9h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 11, 2026